{{Rsnum
|rsid=1898036
|Chromosome=15
|position=36057645
|Orientation=minus
|GMAF=0.09734
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 75.2 | 24.8 | 0.0
| HCB | 71.5 | 26.3 | 2.2
| JPT | 69.9 | 25.7 | 4.4
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 71.5 | 26.3 | 2.2
| CHD | 73.4 | 25.7 | 0.9
| GIH | 66.3 | 27.7 | 5.9
| LWK | 0.0 | 0.0 | 0.0
| MEX | 87.9 | 12.1 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 91.2 | 8.8 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=2E-7
|OR=7.7300
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}